Xiao Bing Li
Corporate Officer/Principal bei CLOVER BIOPHARMACEUTICALS, LTD.
Profil
Xiao Bing Li is currently the Executive Vice President at Clover Biopharmaceuticals Ltd.
Prior to this, he held positions as Senior Director at Ironwood Pharmaceuticals, Director at Janssen Pharmaceuticals, Director at Alkermes Plc, and Senior Director at SAGE Therapeutics.
He also served as Vice President-Program Management at Voyager Therapeutics.
Dr. Li holds a doctorate from Princeton University, an MBA from Colorado State University, and an undergraduate degree from Nankai University.
Aktive Positionen von Xiao Bing Li
| Unternehmen | Position | Beginn |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Corporate Officer/Principal | 27.07.2020 |
Ehemalige bekannte Positionen von Xiao Bing Li
| Unternehmen | Position | Ende |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2018 |
| IRONWOOD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2016 |
| ALKERMES PLC | Direktor/Vorstandsmitglied | 01.07.2014 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Direktor/Vorstandsmitglied | 01.09.2010 |
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Xiao Bing Li
| Nankai University | Undergraduate Degree |
| Princeton University | Doctorate Degree |
| Colorado State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
